M.Preusser summarises results from different trials exploring the use of bevacizumab in brain tumours in adults, highlighting the potential of anti-angiogenesis drugs in this disease.
Share this Video
Related Videos In Neuro-Oncology
Glioblastoma Treatment and Bevacizumab
Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.
Why the Cancer Stem Cell Hypothesis Matters to Childhood Medulloblastoma
Why the Cancer Stem Cell Hypothesis matters to patients with childhood medulloblastoma This presentation will outline the clinical presentation, diagnosis, pathobiology and current best treatment and outcomes of the most common mailgnant childhood brain tumour medulloblastoma. It will also illustrate the application of the cancer stem cell hypothesis to this tumour and will outline novel […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!